Faculty Opinions recommendation of Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.
2015 ◽
Vol 17
(2)
◽
pp. 152-160
◽
Keyword(s):
2013 ◽
Vol 16
(5)
◽
pp. 418-425
◽
Keyword(s):
2017 ◽
Vol 21
(2)
◽
pp. 286
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 13
(7)
◽
pp. 653-661
◽
2009 ◽
Vol 25
(10)
◽
pp. 2361-2371
◽
2014 ◽
Vol 6
(2)
◽
pp. 104-116
◽
Keyword(s):
2012 ◽
Vol 3
(6)
◽
pp. 517-525
◽
Keyword(s):